Stem Cell Therapeutics Graduates to the Toronto Stock Exchange – MarketWatch
|
Stem Cell Therapeutics Graduates to the Toronto Stock Exchange
MarketWatch TORONTO, ONTARIO, Apr 21, 2014 (Marketwired via COMTEX) — Stem Cell Therapeutics Corp. (“SCT”) (CVE:CA:SSS) (otcqx:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announces that its common … |
